Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Levitsky

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Immunologic Research|January 1, 1993
The antitumor immune response as a problem of self-nonself discrimination: implications for immunotherapyP Golumbek, H Levitsky, L Jaffee, et al.
Seminars in Oncology|December 22, 1999
Prostate cancer vaccines: current statusL C Hwang, S Fein, H Levitsky, et al.
Ciba Foundation Symposium|January 1, 1994
Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responsesA Y Huang, P Golumbek, M Ahmadzadeh, et al.
Science (New York, N.Y.)|May 13, 1994
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigensA Y Huang, P Golumbek, M Ahmadzadeh, et al.
The Journal of Experimental Medicine|December 22, 1998
The central role of CD4(+) T cells in the antitumor immune responseK Hung, R Hayashi, A Lafond-Walker, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|November 1, 1992
Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccinesP T Golumbek, F M Hamzeh, E M Jaffee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Induction of antigen-specific T cell anergy: An early event in the course of tumor progressionK Staveley-O'Carroll, E Sotomayor, J Montgomery, et al.
Gene Therapy|August 18, 2006
Vaccinia virus preferentially infects and controls human and murine ovarian tumors in miceC-F Hung, Y-C Tsai, L He, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunityG Dranoff, E Jaffee, A Lazenby, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Immunologic Research|January 1, 1993
The antitumor immune response as a problem of self-nonself discrimination: implications for immunotherapyP Golumbek, H Levitsky, L Jaffee, et al.
Seminars in Oncology|December 22, 1999
Prostate cancer vaccines: current statusL C Hwang, S Fein, H Levitsky, et al.
Ciba Foundation Symposium|January 1, 1994
Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responsesA Y Huang, P Golumbek, M Ahmadzadeh, et al.
Science (New York, N.Y.)|May 13, 1994
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigensA Y Huang, P Golumbek, M Ahmadzadeh, et al.
The Journal of Experimental Medicine|December 22, 1998
The central role of CD4(+) T cells in the antitumor immune responseK Hung, R Hayashi, A Lafond-Walker, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|November 1, 1992
Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccinesP T Golumbek, F M Hamzeh, E M Jaffee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1998
Induction of antigen-specific T cell anergy: An early event in the course of tumor progressionK Staveley-O'Carroll, E Sotomayor, J Montgomery, et al.
Gene Therapy|August 18, 2006
Vaccinia virus preferentially infects and controls human and murine ovarian tumors in miceC-F Hung, Y-C Tsai, L He, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunityG Dranoff, E Jaffee, A Lazenby, et al.
Pageof 1